EIF5A2 mRNA is upregulated in several human tumor cell types such as pancreatic ductal adenocarcinoma, hepatocellular cancer, lung cancer, colorectal cancer, and gastric cancer, indicating that eIF5A2 is a potential oncogene [13, 28–31]. This evidence concerns the gene EIF5A2 and hepatocellular carcinoma.